Avalon GloboCare Corp. (NASDAQ:ALBT) Sees Significant Decline in Short Interest

Avalon GloboCare Corp. (NASDAQ:ALBT) saw a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 78,800 shares, a drop of 27.1% from the October 31st total of 108,100 shares. Based on an average daily trading volume, of 648,600 shares, the days-to-cover ratio is currently 0.1 days. Approximately 19.4% of the shares of the company are short sold.

Avalon GloboCare Stock Performance

ALBT stock opened at $2.80 on Friday. The firm has a market cap of $3.06 million, a PE ratio of -0.14 and a beta of 0.31. The firm’s fifty day moving average is $3.08 and its 200 day moving average is $4.80. Avalon GloboCare has a one year low of $2.11 and a one year high of $21.60.

Avalon GloboCare Company Profile

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.